Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Black Rose Industries Limited (BLACKROSE.BO)
Mumbai, IN
Black Rose Industries Limited primarily focuses on the production and distribution of various chemical products. The company also holds interests in the textile manufacturing sector and the generation of wind power. Its business activities are organized under two principal divisions: Chemicals and an 'Others' segment. This enterprise was established in 1990, with its main offices situated in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.53% | +16.95% | +21.89% | +18.94% | -6.11% | +5.58% | -2.44% | -26.22% | -42.14% | +385.82% | +27,041.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Distribution: +4.8%-17.4% Q1'26: +25.5% (vs Q1'25)
-
EPS growth Industrial - Distribution: +8.9%+7.1% Q1'26: +62.3% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Distribution: +12.0%+10.9% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Industrial - Distribution: +5.8%+8.9% ★ Q1'26: +11.5% (vs Q1'25)
-
ROIC Industrial - Distribution: +7.4%+15.3% ★ Q1'26: +26.1% (vs Q1'25)
-
Share dilution Industrial - Distribution: +0.0%+0.0% Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Distribution: 0.84×0.04× ★ Q1'26: 0.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.96B
est: 1.91B (+55.4%)
|
3.05B
est: 2.16B (+41.3%)
|
3.71B
est: 2.61B (+42.1%)
|
3.76B
est: 2.62B (+43.7%)
|
4.87B
est: 3.42B (+42.4%)
|
4.30B
est: 3.12B (+38.1%)
|
3.79B
est: 2.67B (+42.1%)
|
3.91B
est: 3.67B (+6.7%)
|
4.88B
4.88B – 4.88B
+33.1% YoY
|
| EBITDA |
218.89M
est: 152.81M (+43.2%)
|
247.80M
est: 173.21M (+43.1%)
|
324.91M
est: 209.19M (+55.3%)
|
408.58M
est: 209.81M (+94.7%)
|
469.81M
est: 273.90M (+71.5%)
|
160.57M
est: 249.71M (-35.7%)
|
316.80M
est: 213.88M (+48.1%)
|
292.26M
est: 450.66M (-35.1%)
|
600.03M
600.03M – 600.03M
+33.1% YoY
|
| EBIT |
196.85M
est: 139.36M (+41.3%)
|
221.86M
est: 157.97M (+40.4%)
|
294.25M
est: 190.79M (+54.2%)
|
382.79M
est: 191.35M (+100.0%)
|
443.62M
est: 249.80M (+77.6%)
|
130.22M
est: 227.74M (-42.8%)
|
286.73M
est: 195.06M (+47.0%)
|
260.81M
est: 381.75M (-31.7%)
|
508.29M
508.29M – 508.29M
+33.1% YoY
|
| Net Income |
117.51M
|
138.86M
est: 142.69M (-2.7%)
|
206.74M
est: 224.22M (-7.8%)
|
274.45M
est: 326.14M (-15.9%)
|
318.97M
est: 331.24M (-3.7%)
|
79.19M
est: 219.13M (-63.9%)
|
212.29M
est: 249.70M (-15.0%)
|
209.45M
est: 270.11M (-22.5%)
|
407.71M
407.71M – 407.71M
+50.9% YoY
|
| SGA |
25.25M
est: 33.94M (-25.6%)
|
24.25M
est: 38.47M (-37.0%)
|
26.72M
est: 46.46M (-42.5%)
|
39.58M
est: 46.60M (-15.1%)
|
77.16M
est: 60.84M (+26.8%)
|
95.54M
est: 55.46M (+72.2%)
|
85.70M
est: 47.51M (+80.4%)
|
69.74M
est: 126.99M (-45.1%)
|
169.08M
169.08M – 169.08M
+33.1% YoY
|
| EPS |
2.30
|
2.72
est: 2.80 (-2.9%)
|
4.05
est: 4.40 (-8.0%)
|
5.38
est: 6.40 (-15.9%)
|
6.25
est: 6.50 (-3.8%)
|
1.55
est: 4.30 (-64.0%)
|
4.16
est: 4.90 (-15.1%)
|
4.11
est: 5.30 (-22.5%)
|
8.00
8.00 – 8.00
+50.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ambarish Daga | Joint Chief Financial Officer, Investor Relations Officer & Whole-Time Director | 4M | male |
| Shruti Jatia | Whole-Time Director | 4M | female |
| Bhavesh Shah | General Manager of Sales | — | male |
| Pavankumar Aduri | Vice President Innovation | — | — |
| Ratan Kumar Agrawal | Chief Financial Officer & Chief Risk Officer | — | male |
| Yoshitaka Matsu | President of B.R. Chemicals Co. Ltd | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BLACKROSE.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
